Invention Grant
US06894073B2 Use of diterpene compound as a therapeutic agent of inflammation, immune disease or cancer
失效
使用双萜化合物作为炎症，免疫疾病或癌症的治疗剂
- Patent Title: Use of diterpene compound as a therapeutic agent of inflammation, immune disease or cancer
- Patent Title (中): 使用双萜化合物作为炎症，免疫疾病或癌症的治疗剂
-
Application No.: US10450217Application Date: 2001-12-12
-
Publication No.: US06894073B2Publication Date: 2005-05-17
- Inventor: Jung-Joon Lee , Jeong-Hyung Lee , Hang-Sub Kim , Young-Soo Hong , Bang-Yeon Hwang
- Applicant: Jung-Joon Lee , Jeong-Hyung Lee , Hang-Sub Kim , Young-Soo Hong , Bang-Yeon Hwang
- Applicant Address: KR
- Assignee: Korea Research Institute of Bioscience and Biotechnology
- Current Assignee: Korea Research Institute of Bioscience and Biotechnology
- Current Assignee Address: KR
- Agency: Muserlian, Lucas and Mercanti
- Priority: KR2000-75608 20001212
- International Application: PCTKR01/02152 WO 20011212
- International Announcement: WO0247675 WO 20020620
- Main IPC: A61K31/122
- IPC: A61K31/122 ; C07C45/78 ; C07C49/743 ; C07D493/08 ; A61K31/352 ; C07C49/115 ; C07C49/215 ; C07D311/78
Abstract:
The disclosure concerns novel use of diterpene compound as a therapeutic agent of inlfammation, immune disease or cancer. More particularly, the present invention relates to novel use of diterpene compound that include kamebanin, kamebacetal A, kamebakaurin, and exisanin A, which would be effective for the treatment inflammation, immune disease or cancer by inhibiting the production of nitric oxide, prostaglandin, and TNF-a1 through the suppression of NF-k B activity.
Public/Granted literature
- US20040048918A1 Novel use of diterpene compound as a therapeutic agent of inflammation, immune disease or cancer Public/Granted day:2004-03-11
Information query
